These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 7085002)
1. Peritoneal cell populations during tumour injection. De Heer E; De Groot JW; Den Otter W; Dullens HF Int J Tissue React; 1982; 4(1):81-90. PubMed ID: 7085002 [TBL] [Abstract][Full Text] [Related]
2. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response. Gordon WC; Prager MD Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275 [TBL] [Abstract][Full Text] [Related]
3. Differing contribution of various effector cells in the elimination of syngeneic or allogeneic cells. Matsumoto T; Himeno K; Mitani M; Mori K; Miake S; Nomoto K J Clin Lab Immunol; 1986 Feb; 19(2):83-9. PubMed ID: 3083105 [TBL] [Abstract][Full Text] [Related]
4. Quantitative and ultrastructural changes of peritoneal macrophages in immunized rats after intraperitoneal injection of Novikoff hepatoma. Nanci A; Babaï F; Dumont A J Natl Cancer Inst; 1980 Dec; 65(6):1273-83. PubMed ID: 6933273 [TBL] [Abstract][Full Text] [Related]
5. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system. Gjedde SB Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250 [TBL] [Abstract][Full Text] [Related]
6. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ]. Mazurek C; Stiffel C; Chalvet H; Biozzi G Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973 [TBL] [Abstract][Full Text] [Related]
7. Immune inhibition of allogeneic lymphoma cells in the peritoneal cavity of mice. Fioretti MC; Libarati M; Bonmassar E; Cudkowicz G Cancer Res; 1975 Jan; 35(1):30-6. PubMed ID: 1089042 [TBL] [Abstract][Full Text] [Related]
8. Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes. Simes RJ; Kearney R; Nelson DS Immunology; 1975 Aug; 29(2):343-51. PubMed ID: 1158388 [TBL] [Abstract][Full Text] [Related]
9. Influence of whole body irradiation on intraperitoneal immunity in a syngeneic mouse lymphoma system. Dullens HF; Bouman H; Den Otter W Strahlentherapie; 1979 Jun; 155(6):431-6. PubMed ID: 462489 [TBL] [Abstract][Full Text] [Related]
10. IFN-gamma- and cell-to-cell contact-dependent cytotoxicity of allograft-induced macrophages against syngeneic tumor cells and cell lines: an application of allografting to cancer treatment. Yoshida R; Yoneda Y; Kuriyama M; Kubota T J Immunol; 1999 Jul; 163(1):148-54. PubMed ID: 10384111 [TBL] [Abstract][Full Text] [Related]
11. [Method of efficacious immunization against syngeneic murine sarcoma]. Schaaf-Lafontaine N; Maquet P; De Graef-Lovens D; Courtoy R; Firket H C R Seances Soc Biol Fil; 1985; 179(1):122-7. PubMed ID: 3161594 [TBL] [Abstract][Full Text] [Related]
12. Immunity to lymphoid tumors in syngeneic mice by immunization with mitomycin C-treated cells. Benjamini E; Fong S; Erickson C; Leung CY; Rennick D; Scibienski RJ J Immunol; 1977 Feb; 118(2):685-93. PubMed ID: 839074 [TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved. Cihak J; Ziegler HW; Kölsch E Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346 [TBL] [Abstract][Full Text] [Related]
14. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells. Cihak J; Ziegler HW; Kölsch E Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902 [TBL] [Abstract][Full Text] [Related]
15. Effect of abdominal transplanted mammary tumor on peritoneal fluid cytology in mice. Davis RH; Sackman JW; Kramer DL; Balin H Obstet Gynecol; 1975 Feb; 45(2):190-2. PubMed ID: 1118092 [TBL] [Abstract][Full Text] [Related]
16. Modification of the anti-tumour immune response by suppressor gene products of lymphoid cells. De Giorgi L; Matossian-Rogers A; Festenstein H Immunology; 1979 Apr; 36(4):711-8. PubMed ID: 108205 [TBL] [Abstract][Full Text] [Related]
17. Specific immunoprophylaxis in experimental tumour-host systems. Prager MD; Gordon WC Can Med Assoc J; 1980 Apr; 122(7):780-4. PubMed ID: 7363246 [TBL] [Abstract][Full Text] [Related]
18. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells. Nanishi F; Nomoto K; Taniguchi K; Kubo C Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243 [TBL] [Abstract][Full Text] [Related]
19. Augmentation of the development of immune responses of mice against allogeneic tumor cells after adriamycin treatment. Tomazic V; Ehrke MJ; Mihich E Cancer Res; 1981 Sep; 41(9 Pt 1):3370-6. PubMed ID: 7260903 [TBL] [Abstract][Full Text] [Related]
20. Relationship of cellular proliferation and the generation of cytotoxic cells in an in vitro secondary immune response to syngeneic rat lymphoma cells. Bernstein ID; Cohen EF; Wright PW J Immunol; 1977 Mar; 118(3):1090-4. PubMed ID: 845434 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]